These tables are also available in a printable version (PDF, 222 KB).

Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2012)

ICD-10 Code^ Explanation of Code
B21._ Human Immunodeficiency virus [HIV] disease with malignant neoplasms
C00._ - C97._ Malignant neoplasms
D00._ - D09._ In-situ neoplasms
D18.0, D18.1 Hemangioma and Lymphangioma, any site
D32._ - D33._ Benign neoplasm of meninges (cerebral, spinal and unspecified), brain and other parts of central nervous systems
D35.2 - D35.4 Benign neoplasm of pituitary gland, craniopharyngeal duct, pineal gland
D42._ - D43._ Neoplasm of uncertain or unknown behavior of meninges, brain and central nervous system
D44.3 - D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland
D45, D46._ Polycythemia vera, Refractory Anemia
D47.1, D47.3, D47.7, D47.9 Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
D48.9 Neoplasm of uncertain or unknown behavior, unspecified
D76._ Certain diseases involving lymphoreticular tissue and reticulohistiocytic system

NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.

(This list is to be used to help identify cases that MAY be reportable to the cancer registry. This is not a list of reportable neoplasms or reportable terms)

Supplementary List: ICD-10 Code List to Screen for Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2012)

ICD-10 Code^ Explanation of Code
B20._, B22 - B24 Human immunodeficiency virus [HIV] disease
B99 Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II and 2)
D10._ - D41._, D44._ Benign neoplasms (except for D32._, D33._, D35.2-D35.4) and neoplasms of uncertain or unknown behavior(except for D44.3-D44.5)
D47.0, D47.2 Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
D48._ Neoplasms of uncertain or unknown behavior
D60._, D61._, D63.0, D64._ Aplastic anemias and other anemias (except for D61.0)
D69.4 - D69.9 Other thrombocytopenia
D70 Agranulocytosis
D72.1 Eosinophilia
D75.8 Other specified diseases of blood and blood forming organs
D80.3 - D80.5 Selective deficiency of immunoglobulin
D81.0 - D81.2 Severe combined immunodeficiency [SCID] )
D84.9 Immunodeficiency, unspecified
D89._ Other disorders involving the immune mechanism, not elsewhere classified
E13._ Other specified diabetes mellitus
E31.9 Polyglandular dysfunction, unspecified
E88.0, E88.8 Other metabolic disorders
G31.8 Other specified degenerative diseases of nervous system
G52.8 Disorders of other specified cranial nerves
G54.8 Other nerve root and plexus disorders
G62.8 Other specified polyneuropathies
G70.8 Other specified myoneural disorders
G90.8 Other disorders of autonomic nervous system
G91.8 Other hydrocephalus
G96.8 Other specified disorders of central nervous system
J84.8 Other specified interstitial pulmonary diseases
J90 Pleural effusion, not elsewhere classified
J93.1 Other spontaneous pneumothorax
M12.8 Other specific arthropathies, not elsewhere classified
M62.8 Other specified disorders of muscle
M84.4 Pathologic fracture, not elsewhere classified
M89.8 Other specified disorders of bone
O01._ Hydatidiform mole
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
Q85.0 Neurofibromatosis (nonmalignant) (9540/1)
Q90._ Down’s syndrome
R18 Ascites
R52.9 Pain, unspecified
R53 Malaise and fatigue
R59._ Enlarged lymph nodes
R82.8 Abnormal findings on cytological and histological examination of urine
R83.6, R83.7, R84.6, R84.7, R85.6, R85.7, R86.6, R86.7, R87.6, R87.7, R89.6, R89.7 Abnormal findings on cytological and histological examination of: cerebrospinal fluid, respiratory organs and thorax, digestive organs and abdominal cavity, male genital organs, female genital organs and other organs systems and tissues
R91, R92 Abnormal findings on diagnostic imaging of lung and breast
Y42.1, Y42.6 Adverse reaction to hormone antagonists, antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
Y43.1 - Y43.4 Adverse effects in therapeutic use, antineoplastic products or drugs
Y43.9 Adverse effects in therapeutic use, primarily systemic agent, unspecified
Y44.9 Other and unspecified agents affecting blood constituents
Y63.2 Failure in dosage, overdose of radiation given during therapy
Y81.2 General and plastic surgery devices associated with adverse incidents-prosthetic and other implants, materials, and accessory devices
Y83.0 Surgical operation with transplant of whole organ
Y84.2 Abnormal reaction, radiological procedure and radiotherapy
Y84.9 Other medical procedures (abnormal reaction)

The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.

ICD-10 Code^ Explanation of Code
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
E34.0 Carcinoid syndrome
E34.1 Other hypersecretion of intestinal hormones
E34.8 Other specified endocrine disorders
E83.5 Disorders of calcium metabolism
G04.8 Other encephalitis, myelitis, and encephalomyelitis
H55 Nystagmus and other irregular eye movements
L10.8 Other pemphigus
L30.4 Erythrema intertrigo
L53.8 Other specified erythematous conditions
L83 Acanthosis nigricans
L88 Pyoderma gangrenosum
L98.2 Febrile neutrophilic dermatosis [Sweet]
M33.2 Polymyositis
M33.9 Dermatopolymyositis, unspecified

^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007